Dr. Alan Burguete Torres – Medical Oncologist in Mexico

Dr. Alan Burguete Torres is a Medical Oncologist with a subspecialty in Gastrointestinal Oncology at the Institute of Oncology of Hospital Zambrano Hellion, TecSalud, in San Pedro Garza García, Nuevo León, Mexico. His clinical practice focuses on the diagnosis and medical management of cancers affecting the digestive system, with particular expertise in colorectal, gastric, pancreatic, liver, biliary tract, esophageal, and gastrointestinal neuroendocrine tumors.

Dr. Burguete Torres has developed specialized expertise in gastrointestinal cancer through medical education in Mexico and advanced oncology training in Spain. According to his official TecSalud profile, he studied Medicine at Tecnológico de Monterrey, completed Internal Medicine training there in 2015, and subsequently completed Medical Oncology at the Universidad Autónoma de Nuevo León in 2018. He later pursued a Fellowship in Gastrointestinal Oncology at the Hospital Clínico Universitario de Valencia and completed a Master's degree in Digestive Oncology at UCH Valencia, Spain, in 2021.

Gastrointestinal Oncology Expertise

Gastrointestinal oncology is a highly specialized area of cancer medicine covering tumors of the digestive tract and associated organs. Dr. Burguete Torres' official areas of specialty include oncology of the gastrointestinal system, colorectal cancer, pancreatic cancer, liver and biliary tract cancer, esophageal cancer, gastric cancer, and gastrointestinal neuroendocrine tumors.

Patients with gastrointestinal cancers often require multidisciplinary evaluation because diagnosis and treatment can involve medical oncology, surgery, radiology, pathology, gastroenterology, radiation oncology, nutrition, and supportive care. Medical oncology plays an important role in determining whether systemic treatments may be appropriate before or after surgery or for patients with advanced disease.

Colorectal Cancer Care

Colorectal cancer is one of Dr. Burguete Torres' principal areas of clinical focus. Treatment planning for colon and rectal cancer depends on factors such as tumor location, stage, pathology, molecular characteristics, previous treatments, and the patient's general health.

Depending on the individual diagnosis, treatment may involve surgery, chemotherapy, targeted therapies, immunotherapy, radiation therapy, or combinations of these approaches. A medical oncologist works with other specialists to establish a treatment strategy appropriate for each patient.

Gastric and Esophageal Cancer

Dr. Burguete Torres also specializes in gastric and esophageal cancers. These cancers can require detailed diagnostic evaluation, including imaging, endoscopy, biopsy, pathology, and other investigations.

Treatment depends on the cancer's stage and biological characteristics. Patients may require systemic therapy, surgery, radiation therapy, targeted treatment, immunotherapy, or combined approaches. Specialist oncology care is important for evaluating available treatment options and monitoring the patient's response.

Pancreatic, Liver and Biliary Tract Cancer

Another significant area of his expertise is pancreatic cancer, which can present complex diagnostic and therapeutic challenges. Treatment decisions may require collaboration between medical oncologists, pancreatic surgeons, gastroenterologists, radiologists, pathologists, and other specialists.

His profile also lists liver and biliary tract cancers among his areas of specialty. These cancers include several distinct disease types, and treatment depends on factors such as tumor location, extent of disease, liver function, pathology, and the patient's overall condition.

Gastrointestinal Neuroendocrine Tumors

Dr. Burguete Torres also treats patients with gastrointestinal neuroendocrine tumors. These tumors can differ significantly in their biological behavior and treatment requirements. Accurate classification and staging are important when developing an individualized treatment plan.

Specialist evaluation may involve pathology review, imaging, laboratory assessment, and multidisciplinary consultation. Treatment options vary according to tumor characteristics and disease extent.

Leadership and Clinical Research

Dr. Burguete Torres currently serves as Leader of the Digestive Tumors Clinic at the Institute of Oncology, Hospital Zambrano Hellion, TecSalud. This role reflects his focused professional involvement in gastrointestinal cancer care.

His professional activities also include participation as a researcher in international clinical research protocols involving gastrointestinal cancers. His TecSalud profile lists publications and research contributions addressing topics such as fluoropyrimidine-related toxicity, DPYD genetic variants, gastric adenocarcinoma, patient education in biliary tract cancer, and oncology research practices.

His published work includes research on the frequency of fluoropyrimidine-related toxicity in Mexican patients with colon cancer and investigation of DPYD genetic variants associated with fluoropyrimidine metabolism. These areas are relevant to personalized cancer treatment because individual patients can respond differently to systemic cancer medicines.

Professional Organizations and Certification

Dr. Burguete Torres is listed as an active member of professional organizations including the European Society of Digestive Oncology (ESDO), International Society of Gastrointestinal Oncology (ISGIO), and Sociedad Latinoamericana de Gastroenterología Oncológica (SLAGO). His TecSalud profile also lists certification by the Consejo Mexicano de Oncología, with certification shown as current for the 2023–2028 period.

Care for International Patients

For international patients researching cancer treatment in Mexico, Dr. Alan Burguete Torres can be considered for specialist evaluation of gastrointestinal cancers. International patients should prepare relevant medical documentation before consultation, including pathology reports, biopsy results, CT or MRI scans, PET imaging when applicable, laboratory results, previous treatment records, surgical reports, and current medication information.

Complete medical records can help an oncology specialist understand the patient's previous diagnosis and treatment history and determine whether additional testing or pathology review may be appropriate.

Patients traveling internationally for cancer care should also confirm consultation procedures, estimated treatment costs, appointment availability, medical documentation requirements, accommodation, transportation, and follow-up arrangements before traveling.

Why Consider Dr. Alan Burguete Torres?

Dr. Alan Burguete Torres offers a specialized professional profile in medical oncology and gastrointestinal oncology in Mexico. His clinical focus encompasses colorectal, gastric, esophageal, pancreatic, liver, biliary tract, and gastrointestinal neuroendocrine cancers. His advanced training in Mexico and Spain, leadership of the Digestive Tumors Clinic at Hospital Zambrano Hellion, membership in international oncology organizations, and involvement in gastrointestinal cancer research contribute to his specialist profile.

Patients should understand that cancer treatment is highly individualized. The most appropriate treatment depends on cancer type, stage, pathology, molecular findings, previous treatment, overall health, and other clinical factors. Information on this profile is intended for general informational purposes and should not replace consultation with a qualified oncology professional.

For patients seeking a gastrointestinal oncologist in Monterrey, Mexico, Dr. Alan Burguete Torres can be presented as a specialist at Hospital Zambrano Hellion, TecSalud, with a focused clinical and research background in gastrointestinal cancer care.